Jyong Biotech MENS Cash Flow Statement (2024-2025)

NASDAQ MENS
$2.20 +0.04 (+1.86%)
As of: Aug 21, 2026 · 3:59 PM EDT
Cash Flow Statement Dec2024 Jun2025
Operating Activities
Change in Working Capital
Change in Accured Expenses (Quarter) 41,000.0059,000.00